...
首页> 外文期刊>Scandinavian journal of gastroenterology. >Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study.
【24h】

Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study.

机译:通过基于血清胃蛋白酶原浓度的筛查降低胃癌死亡率:病例对照研究。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: Pepsinogen testing is widely used in Japan as a method of screening for gastric cancer. To evaluate the efficacy of this method, a case-control study was conducted in a rural town in Hiroshima prefecture, Japan, where no previous pepsinogen testing had been performed. MATERIAL AND METHODS: Three age-and gender-matched control subjects were randomly selected for each of 41 individuals who had died of gastric cancer. The three control subjects were selected from individuals who were living in the same area as the patient when gastric cancer was diagnosed. RESULTS: The odds ratios for death from gastric cancer among control subjects screened within 1 and 2 years before the individuals were diagnosed versus those not screened were 0.238 (95% confidence interval (CI): 0.061-0.929), and 0.375 (95% CI: 0.155-0.905), respectively. CONCLUSIONS: The study results suggest that gastric cancer screening using the pepsinogen method may reduce mortality from gastric cancer.
机译:目的:胃蛋白酶原检测在日本被广泛用作胃癌的筛查方法。为了评估该方法的有效性,在日本广岛县的一个农村小镇进行了病例对照研究,该村以前没有进行过胃蛋白酶原的检测。材料与方法:从41位因胃癌死亡的患者中随机选择三名年龄和性别相匹配的对照组。从诊断胃癌时与患者生活在同一地区的个体中选出三个对照对象。结果:在被诊断个体之前和两年内筛查的对照组与未筛查的对照组相比,胃癌死亡的比值比分别为0.238(95%置信区间(CI):0.061-0.929)和0.375(95%CI) :0.155-0.905)。结论:研究结果表明,使用胃蛋白酶原方法筛查胃癌可以降低胃癌的死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号